William B. Horne - 24 Feb 2023 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Director
Signature
/s/ William B. Horne
Issuer symbol
ALZN
Transactions as of
24 Feb 2023
Net transactions value
+$2,000
Form type
4
Filing time
28 Feb 2023, 15:30:44 UTC
Previous filing
11 Jan 2023
Next filing
06 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Options Exercise $2,000 +500,000 +100% $0.004000* 1,000,000 24 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALZN Stock Options (Right to Buy) Options Exercise $0 -500,000 -25% $0.000000 1,500,000 24 Feb 2023 Common Stock 500,000 $0.004000 Direct F2
holding ALZN Stock Options (Right to Buy) 250,000 24 Feb 2023 Common Stock 250,000 $1.50 Direct F3
holding ALZN Stock Options (Right to Buy) 250,000 24 Feb 2023 Common Stock 250,000 $1.50 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to Rule 16b-3 with shares of common stock received upon the exercise of stock options.
F2 The stock options exercised in this transaction were fully vested and exercisable as of the transaction date.
F3 The stock options vest ratably over thirty-six (36) months beginning on the date of grant, and are fully vested.
F4 None of these performance-based stock options are vested or exercisable.